Amgen soars 14% on positive weight-loss drug data

Shares of Amgen Inc. rallied during Friday’s premarket hours after the biotech giant shared upbeat opening-quarter results for fiscal 2024. The company booked $7.4 billion in revenue, surging by 22% c…